CompletedNot Applicable

Ambulant Monitoring to Detect Hemodynamic and Electrical Impact of Severe Tricuspid Valve Regurgitation

Belgium20 participantsStarted 2024-02-01

Plain-language summary

This exploratory study aims to study the feasibility to detect early signs of disease progression in patients with severe TVR (grade ≥3/4) by monitoring electrical cardiac activity and correlating it with echocardiographic findings. The Byteflies monitoring device will be used for continuous 14-day outpatient ECG tracking. Transthoracic echocardiography will assess structural and pressure changes in the heart and liver. The goal is to improve early detection of right heart failure and hepatic congestion.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Tricuspid valve regurgitation (TVR) grade ≥3/4 documented on Colour Doppler during routine transthoracic echocardiography * Normal sinus rhythm * Dutch speaking Exclusion Criteria: * History of cardiac surgery * Abnormal rhythm at baseline visit * Age \<18 years

What they're measuring

Atrial electrical instability

Timeframe: 14 days

Ventricular electrical instability

Timeframe: 14 days

Trial details

NCT IDNCT07043465

SponsorUniversitaire Ziekenhuizen KU Leuven

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-31

View on ClinicalTrials.gov More Tricuspid Regurgitation (TR) trials